Table 1

Patient details and raw bifurcation counts

Patient
ref
DiseaseAgeTotal cryptsCCO+ cryptsCCO−  cryptsCCO partial cryptsTotal bifurcation eventsType I bifurcation events
(% of total)
Type II bifurcation events
(% of total)
Type III bifurcation events
(% of total)
Fission/fusion rate (per crypt per year)
(95% CI)
Duration of fission/fusion (weeks)
(95% CI)
1None794919408649733675 (71.4%)2 (28.6%)00.009 (0.007 to 0.011)3.9 (3.1 to 4.7)
2None6035473424705333 (100%)000.005 (0.001 to 0.009)4.1 (1.3 to 6.8)
3None64695867981015955 (100%)000.002 (0.001 to 0.003)9.1 (2.5 to 15.7)
4FAP67641759102872204441 (93.2%)1 (2.3%)2 (4.5%)0.017 (0.013 to 0.021)10.7 (8.1 to 13.2)
5FAP59409537131931892320 (87.0%)3 (13.0%)00.033 (0.024 to 0.042)4.4 (3.2 to 5.7)
6FAP393085301843244848 (100%)000.010 (0.002 to 0.019)40.7 (6.8 to 74.6)
7aAFAP6454485213148875450 (92.6%)3 (5.6%)1 (1.9%)0.012 (0.008 to 0.017)20.9 (13.3 to 28.6)
7bAFAP64506544632913112520 (80.0%)3 (12.0%)2 (8.0%)0.012 (0.008 to 0.015)11.0 (8.0 to 14.0)
8AFAP6511 75511 3512131912518 (72.0%)07 (28.0%)0.014 (0.010 to 0.018)3.9 (2.8 to 5.1)
9AFAP61417436412822512720 (74.1%)2 (7.4%)5 (18.5%)0.027 (0.021 to 0.034)6.2 (4.7 to 7.7)
10AFAP602038196252241614 (87.5%)1 (6.3%)1 (6.3%)0.011 (0.004 to 0.019)17.1 (6.3 to 28.0)
11aIBD6627225615133 (100%)00NDND
11bIBD6640237821311 (100%)00NDND
12IBD7230123858531 (33.3%)02 (66.7%)NDND
13IBD6512451057102862522 (88.0%)2 (8.0%)1 (4.0%)NDND
14None422702NDNDNDNDNDNDND0.020 (0.006 to 0.034)ND
15None502878NDNDNDNDNDNDND0.009 (0.001 to 0.017)ND
16None502883NDNDNDNDNDNDND0.015 (0.006 to 0.024)ND
17None6212 030NDNDNDNDNDNDND0.007 (0.004 to 0.010)ND
18None6529 839NDNDNDNDNDNDND0.003 (0.002 to 0.004)ND
19None724101NDNDNDNDNDNDND0.005 (0.002 to 0.008)ND
20None748792NDNDNDNDNDNDND0.014 (0.011 to 0.017)ND
21None7422 045NDNDNDNDNDNDND0.012 (0.010 to 0.014)ND
22None806249NDNDNDNDNDNDND0.014 (0.010 to 0.018)ND
23None8210 341NDNDNDNDNDNDND0.016 (0.014 to 0.018)ND
24None8411 821NDNDNDNDNDNDND0.024 (0.020 to 0.028)ND
  • Patients 1–13 had serial sections available and were used to score crypt bifurcation frequencies.

  • Patients 14–24 had only a single section available and were used to assess CCO− patch size.

  • AFAP, attenuated familial adenomatous polyposis; CCO, cytochrome c oxidase; FAP, familial adenomatous polyposis; ND, not detemined.